Evaluation of Silymarin for management of anti-tuberculosis drug induced liver injury: a randomized clinical trial

AIM: This study was performed to evaluate the potential efficacy of silymarin in the management of anti-tuberculosis medication’s induced liver injury. BACKGROUND: Hepatic toxicity is the most serious complication in treatment of tuberculosis. METHODS: In a randomized double blind clinical trial (AC...

Descripción completa

Detalles Bibliográficos
Autores principales: Marjani, Majid, Fahim, Fanak, Sadr, Makan, Kazempour Dizaji, Mehdi, Moniri, Afshin, Khabiri, Shadi, Tabarsi, Payam, Velayati, Ali Akbar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shaheed Beheshti University of Medical Sciences 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536020/
https://www.ncbi.nlm.nih.gov/pubmed/31191838

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536020/
https://www.ncbi.nlm.nih.gov/pubmed/31191838

Ejemplares similares